StonvexLoading…
StonvexCore line items from SO's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $28.94B | $26.76B | $24.83B | $25.94B |
Operating Income | $7.29B | $7.07B | $5.83B | $5.37B |
Net Income | $4.34B | $4.40B | $3.98B | $3.43B |
EPS (Diluted) | $3.92 | $3.99 | $3.62 | $3.26 |
Total Assets | $155.72B | $145.18B | $139.33B | $134.89B |
Total Liabilities | $116.85B | $108.51B | $104.11B | $100.36B |
Cash & Equivalents | $1.64B | $1.07B | $748.00M | $1.92B |
Free Cash Flow OCF − CapEx | $-2.94B | $833.00M | $-1.54B | $-1.62B |
Shares Outstanding | 1.11B | 1.10B | 1.10B | 1.08B |